fosun

Fosun Pharma seals rare H-share placement

The privately-held drug maker raised $296 million from a fully-upsized placement of new H-shares, marking just the second time in nearly three years that a Hong Kong-listed company has sold new shares through a block sale.
May 17, 2017

What if…Fosun Pharma buys Blackmores?

Buying Australia’s leading health supplement brand matches Fosun’s global ambitions — and could also help the target boost its China sales.
April 28, 2017

Chinese sports tycoons shoot for Hong Kong IPOs

HKEx may score a new wave of quasi-international listings as Chinese companies seek to unlock the value of European football club assets and burgeoning domestic investments.
April 17, 2017

Fosun upsizes bond after roaring demand

The Hong Kong-listed company became the first Asian borrower to tap the dollar bond market in the wake of a US interest rate hike. It got a warm welcome from investors
March 17, 2017

Why Chinese and Japanese firms want US insurers

China Oceanwide’s $2.7 billion bid for Genworth Financial continues a long line of Chinese and Japanese companies looking to snap up US insurers. Industry experts worry about regulatory snafus.
October 24, 2016